| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |